A neuronal cell-based botulinum neurotoxin assay for highly sensitive and specific detection of neutralizing serum antibodies |
| |
Authors: | Pellett Sabine Tepp William H Clancy Colin M Borodic Gary E Johnson Eric A |
| |
Affiliation: | Food Research Institute, Department of Bacteriology, University of Wisconsin, Madison, WI 53706, United States. |
| |
Abstract: | Clostridium botulinum neurotoxin (BoNT) serotypes A and B are widely used as pharmaceuticals to treat various neurological disorders and in cosmetic applications. The major adverse effect of these treatments has been resistance to treatment after multiple injections. Currently, patients receiving BoNT therapies and patients enrolled in clinical trials for new applications and/or new formulations of BoNTs are not routinely monitored for the formation of neutralizing antibodies, since no assay other than the mouse protection procedure is commercially available that reliably tests for the presence of such antibodies. This report presents a highly sensitive and specific neuronal cell-based assay that provides sensitive and specific detection of neutralizing antibodies to BoNT/A. |
| |
Keywords: | Botulinum neurotoxin BoNT Serum antibody Cell-based assay Spinal cord cell |
本文献已被 ScienceDirect PubMed 等数据库收录! |